Ultraviolet A in vitiligo.

Area of Science:

• Dermatology
• Photobiology
• Medical research

Background:

• Ultraviolet (UV) radiation, including UVB and UVA, is known to induce skin pigmentation.
• Previous research has not evaluated the efficacy of UVA radiation alone for treating vitiligo.
• Vitiligo is a condition characterized by loss of skin pigmentation.

Purpose of the Study:

• To investigate the pigment-inducing effects of UVA radiation in patients with vitiligo.
• To determine the therapeutic potential of UVA monotherapy for vitiligo treatment.
• To compare the efficacy of two different UVA doses (5 J/cm² and 15 J/cm²) in vitiligo patients.

Main Methods:

• Twenty randomly selected vitiligo patients with extensive (over 30% body surface area) and symmetrical skin involvement were enrolled.
• Patients were divided into two groups of ten.
• Group I received 15 J/cm² UVA, and Group II received 5 J/cm² UVA, three times weekly for 16 weeks (48 sessions total).

Main Results:

• Significant overall pigmentation (60% or more) was observed in 50% of patients in Group I (15 J/cm² UVA).
• Only 10% of patients in Group II (5 J/cm² UVA) achieved 60% or more overall pigmentation.
• The study demonstrated a dose-dependent pigmentogenic response to UVA in vitiligo.

Conclusions:

• Broadband UVA radiation alone, without the use of psoralens, can be therapeutically valuable for vitiligo.
• Appropriate UVA dosing is crucial for achieving significant repigmentation in vitiligo patients.
• UVA monotherapy presents a promising and potentially safer treatment option for vitiligo.